Critical appraisal:Palmer JD, Schneider CJ, Hockstein N, Hanlon AL, Silberg J, Strasser J, et al 2018

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Selected group
Comparison group
Selected group
Comparability of groups on demographic characteristics and clinical features
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
Moderate risk of bias Additional comments:

Jutta's tick icon.png This appraisal has been completed.

Palmer JD, Schneider CJ, Hockstein N, Hanlon AL, Silberg J, Strasser J, et al. Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis. Oral Oncol 2018 Mar;78:102-107 Available from:
Assigned to
Topic area
Guidelines:Keratinocyte carcinoma
Clinical question
Form:Quality appraisal cohort
Overall survival; Progression-free survival

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment